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tributed to an increased frequency of severe fungal infections in
patients with neoplastic diseases. Incidence due to ﬁlamentous
fungi becomes life-threatening and their diagnosis and treatment
can be challenging, especially in species with intrinsic resistance.
Diagnosis of ﬁlamentous fungi in both the clinic and the labora-
tory remains difﬁcult, leading to unsatisfactory treatment and high
mortality rates.
Methods & Materials: A total of 40 clinical specimens includ-
ing surgical tissues, biopsies andwound swabswere collected from
Cancer patients and cultured on fungal isolationmedium. The pres-
ence of fungal elements on tissue specimens were demonstrated
using PAS stain by histopathological analysis. The positive fungal
isolates were presumptively identiﬁed based on macroscopic and
microscopic features and species were further conﬁrmed by PCR
ampliﬁcation of ITS followed by sequencing the amplicons. The
Antifungal susceptibility proﬁles of fungal isolates to Amphotericin
B and Itraconazolewas determined bymicrobroth dilution assay as
per CLSI guidelines.
Results: Out of 40 specimens collected, 16 were positive for
ﬁlamentous fungi. Based on phenotypic identiﬁcation and ITS
sequencing 9 were found to be rare isolates and were identiﬁed
asGeotrichum candidum (03), Curvularia verruculosa (01), Alternaria
alternata (01), Fusarium incarnatum (01), Syncephalastrum racemo-
sum (01), Penicillium oxalicum (01) and Onychocola canadensis (01).
The MIC values of Amphotericin B and Itraconazole ranged from
0.0625 to>16 g/ml. All the isolates were found to be suscepti-
ble to Amphotericin B and Itraconazole, while G. candidum showed
resistance to Itraconazole and single isolate ofO. canadensis showed
resistance to both the antifungals.
Conclusion: The results obtained in the study showed the
occurence of rare fungal isolates such as G. candidum, C. verrucu-
losa, A. alternata, F. incarnatum, S. racemosum, P. oxalicum and O.
canadensis in cancer patients. The Amphotericin B and Itraconazole
were found to be more effective antifungals against all the species
tested except few rare isolates with intrinsic resistance. However,
therapeutic success in cases of fungal infections primarily depends
on early diagnosis of the fungal infection, correct identiﬁcation of
the etiologic agent, and timely antifungal treatment.
http://dx.doi.org/10.1016/j.ijid.2016.02.679
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Background: Cryptococcal meningitis remains one of the lead-
ing causes of morbidity and mortality among immunosuppressed
individuals, particularly thosewithHIV infection. Globally, approx-
imately one million cases occur each year resulting in more than
six lakh deaths.
Although incidence of cryptococcal meningoencephalitis has
declined in patients who have access to anti retroviral therapy,
it still remains a prominent cause of morbidity and mortality in
developing world where access to ART is limited.
We have analysed the cases of cryptococcal meningitis over a
period of thirty ﬁve years in pre and post HIV era.
Methods &Materials: This retrospective and prospective study
wasdone in thedepartmentofneuromicrobiology,NIMHANS, a ter-
tiary neurocentre of South India, from January 1979 to December
2014. Diagnosis was based on india ink preparation, antigen detec-
tion, and culture by standard laboratorymethods. Serotype,mating
type and genotype were determined by molecular methods in few
of the isolates.
Results: In 1988, ﬁrst case of HIV associated cryptococcal
meningitis was diagnosed in NIMHANS. During 1996 to 2003, HIV
positivity in cryptococcal meningitis was 94-96%. The incidence of
cryptococcal meningitis among HIV negative patients has been on
the rise reaching upto 17.25% in 2014.
A total of 1230 cases of cryptococcal meningitis were analysed,
ofwhich tenwere fromthepreHIVera(1986). Theagegroup ranged
from 2-76 years, and the disease was most prevalent in the 30-40
age group. Onset of the clinical symptoms ranged from 4 days to 6
months. Headache was the commonest symptom followed by high
or intermittent fever and vomiting. Patients also had neck stiffness
(90%), altered sensorium(65%), behavioural changes (50%), blurring
of vision (30%)etc.
CSF cell count ranged from0- 400 cell/cummwith predominatly
lymphocytes. India ink was positive among 90% and fungal culture
was positive in all the cases.
Among C. neoformans, 4-11% belonged to biovar. gattii. Of the
isolates tested, serotype‘A’was predominant and all were ofmating
type alpha. 97.5% isolates were sensitive to amphotericin B and
90.2% to ﬂuconazole.
Conclusion: A high index of suspicion is needed for early diag-
nosis as many would recover with timely and adequate antifungal
therapy.
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Background: Cryptococcal meningitis is an AIDs deﬁning ill-
ness. However the disease is seen in patients without HIV infection
also. Attempts have beenmade to develop a vaccine for the disease,
so the prevalent genotypes of Cryptococcal neoformans need to be
identiﬁed. In the Indian scenario there is a paucity of literature on
MLST genotyping. Genotyping of C. neoformans can be performed
for epidemiological purpose, to determine whether the cryptococ-
cosis is caused by single genotype or two or more genotypes and
